Adverse prognostic significance of infraclavicular lymph nodes detected byultrasonography in patients with locally advanced breast cancer

Citation
La. Newman et al., Adverse prognostic significance of infraclavicular lymph nodes detected byultrasonography in patients with locally advanced breast cancer, AM J SURG, 181(4), 2001, pp. 313-318
Citations number
22
Categorie Soggetti
Surgery,"Medical Research Diagnosis & Treatment
Journal title
AMERICAN JOURNAL OF SURGERY
ISSN journal
00029610 → ACNP
Volume
181
Issue
4
Year of publication
2001
Pages
313 - 318
Database
ISI
SICI code
0002-9610(200104)181:4<313:APSOIL>2.0.ZU;2-H
Abstract
Background: Ultrasonography is increasingly used to evaluate the nodal stat us of breast cancer patients and specialized positioning permits assessment of the infraclavicular fossa. However, the incidence and significance of i nfraclavicular (level III) adenopathy detected sonographically in locally a dvanced boast cancer (LABC) has not been defined. Methods: The study population consisted of 146 LABC patients registered in a prospective trial of induction chemotherapy between 1991 and 1996. All pa tients underwent ultrasound imaging before and after chemotherapy. Median f ollow-up was 32 months. Results: Forty-two of 146 patients (29%) had suspicious infraclavicular ade nopathy; all 42 had additional positive axillary lymph nodes by ultrasound. Disease-free and overall survival for the patients with suspicious infracl avicular adenopathy was significantly worse compared with patients without this feature; disease-free survival 50% versus 68% (P = 0.112); overall sur vival 58% versus 83% (P = 0.026). Conclusions: Nearly one third of LABC patients will have infraclavicular ly mph node involvement by ultrasound imaging; this finding is a significant a dverse prognostic feature, and we recommend that infraclavicular nodal eval uation become a routine component of the sonographic workup of breast cance r patients, particularly if lower axillary lymph nodes appear involved. (C) 2001 Excerpta Medica, Inc. All rights reserved.